![]() |
市场调查报告书
商品编码
1953820
伤口护理器材市场-全球产业规模、份额、趋势、机会、预测:按伤口类型、产品、最终用户、地区和竞争对手划分,2021-2031年Wound Therapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Wound Type, By Product, By End-User, By Region & Competition, 2021-2031F |
||||||
全球伤口护理市场预计将从 2025 年的 49.6 亿美元成长到 2031 年的 68.9 亿美元,复合年增长率为 5.63%。
这些设备包括负压治疗系统和高压氧气疗法舱,它们是专门用于促进急性和慢性损伤的治疗和癒合的设备。推动市场成长的主要因素是全球范围内与文明病(例如肥胖和糖尿病)的增加,这些疾病显着提高了复杂性溃疡的发生率。此外,全球人口老化也是推动市场需求的因素之一,因为老年患者的生理癒合能力往往下降,更容易发生褥疮等压力性损伤。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 49.6亿美元 |
| 市场规模:2031年 | 68.9亿美元 |
| 复合年增长率:2026-2031年 | 5.63% |
| 成长最快的细分市场 | 负压伤口治疗(NPWT) |
| 最大的市场 | 北美洲 |
然而,购置先进治疗设备的成本极为高昂,严重阻碍了市场发展。儘管对专科护理的需求日益增长,但在经济敏感地区,此类设备的普及却受到限制。儘管需要此类治疗的患者人数不断增加,但这种经济障碍仍然是一大阻碍。根据国际糖尿病联盟(IDF)预测,到2024年,全球将有约5.89亿成年人患有糖尿病,而糖尿病与慢性伤口的发生密切相关。这项数据凸显了开发价格合理的治疗性介入以减轻医疗基础设施日益沉重负担的迫切需求。
文明病和慢性病在全球范围内的日益流行,为全球伤口护理器材市场奠定了至关重要的基础。糖尿病和肥胖等代谢紊乱会显着损害生理癒合机制,增加慢性皮肤损伤和难治性溃疡的发生率,而这些疾病需要更高阶的治疗。随着这些疾病的日益普遍,需要长期创伤护理的患者数量也在增加,因此亟需引入生物活性器材和负压伤口治疗技术,以预防截肢和感染。根据世界肥胖联盟于2024年3月发布的《2024年世界肥胖地图集》,目前全球有超过10亿人患有肥胖症,这与压疮和静脉溃疡的风险增加直接相关。如此庞大的患者群体推动了对用于治疗复杂难癒合伤口的器械的持续需求。
同时,烧烫伤和创伤病例的不断增加,使得有效的伤口管理和闭合系统变得特别重要。严重的身体创伤和烧烫伤需要长期、即时的治疗支持以恢復组织完整性,这使得专用医疗设备在急诊环境中至关重要。正如2024年3月发表在《烧伤》(Burns)杂誌上的研究报告《全球烧烫伤负担及其与社会经济发展的关係》所指出的,全球严重烧烫伤的患病人数估计为1299万,凸显了急性创伤给医疗保健提供者带来的巨大负担。这种迫切的需求正在推动市场显着成长,医疗保健系统正在采用先进的管理解决方案。例如,史密斯医疗(Smith+Nephew)在2024年2月发布的2023年第四季度和全年财务业绩报告中显示,其先进伤口管理业务的核心收入增长了6.4%,这表明这些技术在全球市场得到了持续应用。
先进医疗器材的高昂采集费用严重阻碍了全球伤口护理器材市场的成长。许多医疗机构,尤其是公立医疗系统和发展中地区的医疗机构,预算捉襟见肘,难以负担负压伤口治疗系统等昂贵技术。因此,这些专业器材的应用往往仅限于私立医疗机构和富裕的都市区。这种经济差距迫使价格敏感的市场依赖更经济的传统替代方案,抑制了製造商的潜在利润,并延缓了先进解决方案的普及。
鑑于需要有效伤口管理的患者数量庞大,此经济障碍尤其具有限制性。根据2024年伤口、造口和失禁护理(WOCN)数据,光是在美国,下肢动脉疾病患者就估计达650万人。此类疾病的高发生率表明迫切需要有效的治疗方法。然而,先进医疗设备所需的高额资本投入阻碍了其在不断增长的患者群体中的普及,直接限制了市场成长。
一次性负压伤口治疗 (NPWT) 系统的出现,从根本上改变了市场格局,为传统的、资本密集型设备提供了一种便携且经济高效的替代方案。与笨重的罐式装置不同,这些紧凑的一次性设备使患者能够在居家照护环境中接受持续治疗,从而显着提高患者的活动能力并缩短住院时间。这种转变消除了维护和购买昂贵硬体的需求,从而减轻了高级创伤护理相关的经济负担。主要产业领导者的财务表现也印证了这些产品的快速普及。例如,在2024年2月发布的2023年第四季度和全年收益报告中,史密斯医疗 (Smith+Nephew) 报告称,其高级伤口护理设备部门的基本收入实现了两位数的增长,这主要得益于对一次性 PICO 负压伤口治疗系统的强劲需求。
同时,人工智慧驱动的自动化伤口评估技术的整合正在革新临床工作流程,以精准的数位分析取代主观的人工评估。人工智慧平台现在利用智慧型手机的标准相机捕捉伤口影像,并自动计算组织成分和表面积,从而高精度地监测癒合过程。这种技术协同作用透过促进标准化记录和早期发现併发症,改善了临床决策,在慢性病管理中发挥至关重要的作用。目前,该领域正投入大量资金以增强这些数位化能力。正如2024年1月发布的公告「Swift Medical融资800万美元推进人工智慧驱动的创伤护理」中所述,Swift Medical成功资金筹措了800万美元,用于加速其人工智慧平台的开发。该公司的平台目前已部署在4,000多家医疗机构。
The Global Wound Therapy Devices Market is projected to expand from USD 4.96 Billion in 2025 to USD 6.89 Billion by 2031, reflecting a compound annual growth rate of 5.63%. These devices, which include negative pressure systems and hyperbaric chambers, are specialized instruments engineered to expedite the management and healing of both acute and chronic injuries. A primary catalyst for this market growth is the rising global incidence of lifestyle-related conditions, such as obesity and diabetes, which drastically increase the occurrence of complex ulcers. Furthermore, the aging global demographic continues to fuel demand, as geriatric patients often experience diminished physiological healing capacities and are more prone to pressure injuries.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.96 Billion |
| Market Size 2031 | USD 6.89 Billion |
| CAGR 2026-2031 | 5.63% |
| Fastest Growing Segment | Negative Pressure Wound Therapy (NPWT) |
| Largest Market | North America |
However, market progression is notably hindered by the substantial acquisition costs of advanced therapeutic equipment, restricting their adoption in economically sensitive regions despite the expanding need for specialized care. This financial obstacle remains a significant hurdle even as the patient population requiring such treatment grows. According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024, a condition heavily linked to chronic wound prevalence. This statistic highlights the critical requirement for affordable therapeutic interventions to alleviate the mounting pressure on healthcare infrastructure.
Market Driver
The surging global prevalence of lifestyle-related and chronic diseases establishes a crucial basis for the Global Wound Therapy Devices Market. Metabolic disorders like diabetes and obesity significantly impair physiological healing mechanisms, resulting in a higher incidence of chronic skin defects and hard-to-heal ulcers that demand sophisticated intervention. As these conditions become more ubiquitous, the volume of patients necessitating long-term wound care grows, requiring the deployment of bioactive devices and negative pressure wound therapy to avert amputation and infection. According to the 'World Obesity Atlas 2024' released by the World Obesity Federation in March 2024, over one billion individuals globally are currently living with obesity, a factor directly linked to increased vulnerability to pressure injuries and venous leg ulcers. This immense patient demographic fuels a persistent need for devices designed to manage complex, non-healing wounds.
Simultaneously, the increasing frequency of burn cases and traumatic injuries necessitates effective systems for wound management and closure. Severe physical trauma and burns demand prolonged, immediate therapeutic assistance to reestablish tissue integrity, rendering specialized devices indispensable in acute care environments. As noted in the study 'Global burden of burns and its association with socio-economic development status' published in the journal Burns in March 2024, the global prevalence of severe burn injuries was estimated at 12.99 million, emphasizing the significant load acute injuries place on healthcare providers. This urgent demand translates into measurable market growth as health systems procure advanced management solutions. For example, Smith+Nephew reported in their 'Fourth Quarter and Full Year 2023 Results' in February 2024 that their Advanced Wound Management unit achieved 6.4% underlying revenue growth, indicating sustained uptake of these technologies in global markets.
Market Challenge
The substantial acquisition expenses linked to advanced therapeutic equipment pose a significant barrier to the growth of the global wound therapy devices market. Numerous healthcare institutions, particularly those within publicly funded systems and developing regions, function under tight budget limitations that restrict their capacity to procure costly technologies like negative pressure wound therapy systems. As a result, the deployment of these specialized devices is frequently limited to private facilities or wealthy urban centers. This economic disparity necessitates a dependence on traditional, less expensive alternatives in price-sensitive markets, effectively curtailing the potential revenue for manufacturers and retarding the broader penetration of sophisticated solutions.
This financial hurdle is especially restrictive given the vast patient population in need of effective wound management. According to data from the Wound, Ostomy, and Continence Nurses Society in 2024, lower extremity arterial disease was estimated to impact 6.5 million individuals in the United States alone. The high incidence of such conditions suggests an urgent requirement for effective healing treatments. Nevertheless, the prohibitive capital investment needed for advanced devices precludes their widespread adoption for this growing patient group, directly impeding the market's growth trajectory.
Market Trends
The emergence of Single-Use and Disposable Negative Pressure Wound Therapy (NPWT) Systems is fundamentally transforming the market by providing portable, cost-efficient alternatives to conventional, capital-heavy equipment. In contrast to cumbersome canister-based units, these compact disposable devices allow patients to undergo continuous therapy within home care environments, greatly improving mobility and decreasing the duration of hospital stays. This transition mitigates the economic challenges of advanced wound care by removing the necessity for costly hardware maintenance and purchases. The swift adoption of these products is evident in the financial results of major industry leaders; for instance, Smith+Nephew reported in their 'Fourth Quarter and Full Year 2023 Results' in February 2024 that their Advanced Wound Devices division realized double-digit underlying revenue growth, largely fueled by strong demand for their single-use PICO Negative Pressure Wound Therapy System.
Concurrently, the integration of Artificial Intelligence for Automated Wound Assessment is revolutionizing clinical workflows by substituting subjective manual evaluations with accurate digital analysis. AI-driven platforms now leverage standard smartphone cameras to capture wound images, automatically computing tissue composition and surface area to monitor healing progress with high precision. This technological synergy improves clinical decision-making by standardizing documentation and facilitating the early identification of complications, which is essential for chronic condition management. The sector is witnessing substantial capital investment to bolster these digital capabilities. As announced in 'Swift Medical Secures $8M to Power AI-Driven Wound Care' in January 2024, Swift Medical successfully raised $8 million specifically to expedite the development of its AI platform, which currently serves more than 4,000 healthcare facilities.
Report Scope
In this report, the Global Wound Therapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Wound Therapy Devices Market.
Global Wound Therapy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: